Literature DB >> 25966635

Genetics of GNE myopathy in the non-Jewish Persian population.

Alireza Haghighi1,2,3, Shahriar Nafissi4, Abrar Qurashi5, Zheng Tan5, Hosein Shamshiri4, Yalda Nilipour6, Amirreza Haghighi7, Robert J Desnick5, Ruth Kornreich5.   

Abstract

GNE myopathy is an autosomal recessive adult-onset disorder characterized by progressive muscle atrophy and weakness, initially involving the distal muscles, while often sparing the quadriceps. It is caused by variants in the GNE gene that encodes a key bifunctional enzyme in the sialic acid biosynthetic pathway. We investigated the clinical and molecular characteristics of 18 non-Jewish Persian patients from 11 unrelated GNE myopathy families. In addition, we reviewed the previously reported cases and suggest genotype-phenotype correlations for the identified variants. Comprehensive clinical and laboratory evaluations were carried out. Sequencing of the GNE gene was performed using genomic DNA from the patients. Screening of the identified variants was performed in all relevant family members. Molecular analyses identified three causative homozygous GNE variants in 11 families: c.2228T>C (p. M743T) in 7, c.830G>A (p.R277Q) in 2, and one novel variation (c.804G>A) in 2 families that results in a synonymous codon change (p.L268=) and likely creates a novel splice site affecting the protein function. This study confirms that c.2228T>C (p.M743T) is the most prevalent disease-causing variant in the non-Jewish Persian population, but other GNE variants can cause GNE myopathy in this population. The patients with all three different variants had similar ages of onset. The youngest patient was an 18-year-old girl in whom the c.830G>A (p.R277Q) variant was identified, whereas the oldest onset age (31 years) was seen in a male patient with c.804G>A (p.L268=). The results of this investigation expand our knowledge about the genotype-phenotype correlations in GNE myopathy and aid in clinical management and therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966635      PMCID: PMC4717203          DOI: 10.1038/ejhg.2015.78

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  49 in total

1.  Distal myopathy with rimmed vacuoles: report on clinical characteristics in 23 cases.

Authors:  A Nalini; N Gayathri; Rose Dawn
Journal:  Neurol India       Date:  2010 Mar-Apr       Impact factor: 2.117

2.  Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations.

Authors:  Madoka Mori-Yoshimura; Kazunari Monma; Naoki Suzuki; Masashi Aoki; Toshihide Kumamoto; Keiko Tanaka; Hiroyuki Tomimitsu; Satoshi Nakano; Masahiro Sonoo; Jun Shimizu; Kazuma Sugie; Harumasa Nakamura; Yasushi Oya; Yukiko K Hayashi; May Christine V Malicdan; Satoru Noguchi; Miho Murata; Ichizo Nishino
Journal:  J Neurol Sci       Date:  2012-04-14       Impact factor: 3.181

3.  Distal myopathy with rimmed vacuoles: clinical and muscle morphological characteristics and spectrum of GNE gene mutations in 53 Chinese patients.

Authors:  Xianghui Lu; Chuanqiang Pu; Xusheng Huang; Jiexiao Liu; Yanling Mao
Journal:  Neurol Res       Date:  2011-12       Impact factor: 2.448

4.  The spectrum of GNE mutations: allelic heterogeneity for a common phenotype.

Authors:  Marina Grandis; Rossella Gulli; Denise Cassandrini; Elisabetta Gazzerro; Luana Benedetti; Eleonora Narciso; Lucilla Nobbio; Claudio Bruno; Carlo Minetti; Emilia Bellone; Lizia Reni; Giovanni Luigi Mancardi; Paola Mandich; Angelo Schenone
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

5.  Clinical and molecular genetic analysis in Chinese patients with distal myopathy with rimmed vacuoles.

Authors:  Honghao Li; Qi Chen; Fuchen Liu; Xuemei Zhang; Tao Liu; Wei Li; Shuping Liu; Yuying Zhao; Bing Wen; Tingjun Dai; Pengfei Lin; Yaoqin Gong; Chuanzhu Yan
Journal:  J Hum Genet       Date:  2011-02-10       Impact factor: 3.172

Review 6.  Hereditary inclusion body myopathy: a decade of progress.

Authors:  Marjan Huizing; Donna M Krasnewich
Journal:  Biochim Biophys Acta       Date:  2009-07-24

7.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

Authors:  May Christine V Malicdan; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

8.  Limb-girdle phenotype is frequent in patients with myopathy associated with GNE mutations.

Authors:  Young-Eun Park; Hyang-Suk Kim; Eun-Suk Choi; Jin-Hong Shin; Sun-Young Kim; Eun-Hui Son; Chang-Hoon Lee; Dae-Seong Kim
Journal:  J Neurol Sci       Date:  2012-08-09       Impact factor: 3.181

9.  Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.

Authors:  Terren K Niethamer; Tal Yardeni; Petcharat Leoyklang; Carla Ciccone; Adrian Astiz-Martinez; Katherine Jacobs; Heidi M Dorward; Patricia M Zerfas; William A Gahl; Marjan Huizing
Journal:  Mol Genet Metab       Date:  2012-10-18       Impact factor: 4.797

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more
  8 in total

1.  Quantitative nuclear magnetic resonance imaging detects subclinical changes over 1 year in skeletal muscle of GNE myopathy.

Authors:  Teresa Gidaro; Harmen Reyngoudt; Julien Le Louër; Anthony Behin; Ferial Toumi; Melanie Villeret; Ericky C A Araujo; Pierre-Yves Baudin; Benjamin Marty; Melanie Annoussamy; Jean-Yves Hogrel; Pierre G Carlier; Laurent Servais
Journal:  J Neurol       Date:  2019-10-15       Impact factor: 4.849

2.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

3.  Generation and Characterization of a Skeletal Muscle Cell-Based Model Carrying One Single Gne Allele: Implications in Actin Dynamics.

Authors:  Shamulailatpam Shreedarshanee Devi; Rashmi Yadav; Fluencephila Mashangva; Priyanka Chaudhary; Shweta Sharma; Ranjana Arya
Journal:  Mol Neurobiol       Date:  2021-09-12       Impact factor: 5.590

4.  Phenotypic stratification and genotype-phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion.

Authors:  Oksana Pogoryelova; Phillip Cammish; Hank Mansbach; Zohar Argov; Ichizo Nishino; Alison Skrinar; Yiumo Chan; Shahriar Nafissi; Hosein Shamshiri; Emil Kakkis; Hanns Lochmüller
Journal:  Neuromuscul Disord       Date:  2017-11-14       Impact factor: 4.296

Review 5.  GNE myopathy: from clinics and genetics to pathology and research strategies.

Authors:  Oksana Pogoryelova; José Andrés González Coraspe; Nikoletta Nikolenko; Hanns Lochmüller; Andreas Roos
Journal:  Orphanet J Rare Dis       Date:  2018-05-02       Impact factor: 4.123

6.  Identification of a GNE homozygous mutation in a Han-Chinese family with GNE myopathy.

Authors:  Yuan Wu; Lamei Yuan; Yi Guo; Anjie Lu; Wen Zheng; Hongbo Xu; Yan Yang; Pengzhi Hu; Shaojuan Gu; Bingqi Wang; Hao Deng
Journal:  J Cell Mol Med       Date:  2018-08-29       Impact factor: 5.310

7.  GNE genotype explains 20% of phenotypic variability in GNE myopathy.

Authors:  Oksana Pogoryelova; Ian J Wilson; Hank Mansbach; Zohar Argov; Ichizo Nishino; Hanns Lochmüller
Journal:  Neurol Genet       Date:  2019-02-01

8.  Expanding the clinicopathological-genetic spectrum of GNE myopathy by a Chinese neuromuscular centre.

Authors:  Kai-Yue Zhang; Hui-Qian Duan; Qiu-Xiang Li; Yue-Bei Luo; Fang-Fang Bi; Kun Huang; Huan Yang
Journal:  J Cell Mol Med       Date:  2021-10-22       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.